drugset / Trial / NCT00014248

Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors

NCT00014248

Supportive care

Summary

RATIONALE: Adenosine triphosphate may decrease weight loss and improve muscle strength in patients with advanced solid tumors. PURPOSE: Phase I trial to study the effectiveness of adenosine triphosphate in controlling loss of weight and loss of muscle mass in patients who have advanced solid tumors.

Timeline

Start
2000-10
Primary completion
2002-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject adenosine triphosphate Small molecule Intravenous